The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. NextGen Healthcare’s stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.92%), Dimensional Fund Advisors LP (3.75%), State Street Corp (3.06%), William Blair Investment Management LLC (2.93%), Geode Capital Management LLC (1.67%) and Kennedy Capital Management LLC (1.40%). Insiders that own company stock include Craig A Barbarosh, David A Metcalfe, David Ahmadzai, David William Sides, Donna Cullen Greene, George H Bristol, James Robert Jr Arnold, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor. The healthcare technology company topped Wall Street estimates on both its top and bottom lines in the third quarter.
The company is going private at a handsome premium, hence the increase. As of early Friday morning, week to date NextGen’s soon-to-vanish shares were up 22% in value, per data compiled by S&P Global Market Intelligence. Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
Thoma Bravo is one of the largest software investors in the world, with more than US$131 billion in assets under management as of June 30, 2023. Through its private equity, growth equity and credit strategies, the firm invests in growth-oriented, innovative companies operating in the software and technology sectors. Leveraging Thoma Bravo’s deep sector expertise and strategic and operational capabilities, the firm collaborates with its portfolio companies to implement operating best practices and drive growth initiatives. Over the past 20 years, the firm has acquired or invested in more than 440 companies representing over US$250 billion in enterprise value (including control and non-control investments). The firm has offices in Chicago, London, Miami, New York and San Francisco. For more information, visit Thoma Bravo’s website at thomabravo.com.
Stock Money Flow
Style is calculated by combining value and growth scores, which are first individually calculated. Thoma Bravo maintains a portfolio of strong cybersecurity companies. This situation presents an opportunity for NextGen developers to prioritize security in software re-engineering and to use solutions from the portfolio to enhance the product’s security even more.
Rather quickly after that announcement, NextGen’s share price rose sharply to nearly the price Thoma Bravo agreed to pay in the buyout. Upgrade to MarketBeat All Access to add more stocks to your watchlist. 248 employees have rated NextGen Healthcare Chief Executive Officer Rusty Frantz cagr vs irr on Glassdoor.com. Rusty Frantz has an approval rating of 72% among the company’s employees. Click the link below and we’ll send you MarketBeat’s list of seven stocks and why their long-term outlooks are very promising. Companies do not pay for placement on Forbes list rankings.
Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. In the press release announcing the buyout, NextGen said it has been approved unanimously by its board of directors. The deal is anticipated to close at some point in the fourth calendar quarter of this year, the company added. Following news of the deal, several analysts tracking NextGen reassessed their takes on the stock.
– Upon completion of the acquisition, NextGen Healthcare’s common stock will no longer be listed on any public stock exchange and will become a privately held company. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed.
Although NextGen recently reached a $31 million settlement over some of its business practices, several key fundamentals have been growing. In its latest reported quarter, the specialty healthcare services provider delivered double-digit revenue and net income growth on a year-over-year basis. The Company and its directors, executive officers and certain other members of management https://1investing.in/ and employees may be deemed to be participants in soliciting proxies from its stockholders in connection with the proposed Merger. Additional information regarding these individuals and any direct or indirect interests they may have in the proposed Merger will be set forth in the definitive proxy statement when and if it is filed with the SEC in connection with the proposed Merger.
According to the proposed terms, NextGen shareholders will get $23.95 in cash for each share they own. Law firms aim to assess whether this payout and the process leading to it are adequate or if they undervalue the company. Healthcare organizations considering using NextGen’s products and services should monitor the acquisition closely and be prepared for any potential changes. A new owner could introduce a new strategic vision for the company, potentially focusing on increasing profitability, scaling the business, or preparing the company for a future sale.
- RBC Capital’s Sean Dodge was one of the pundits raising his price target; he lifted it to $23.95 per share, matching the buyout price.
- The company issued revenue guidance of $714.00 million-$722.00 million, compared to the consensus revenue estimate of $717.95 million.
- Thoma Bravo is one of the largest software investors in the world, with more than US$131 billion in assets under management as of June 30, 2023.
- Although NextGen recently reached a $31 million settlement over some of its business practices, several key fundamentals have been growing.
- NextGen partner ecosystem developing healthcare technology solutions should also monitor any potential changes, while on the positive side, they can consider Thoma Bravo as a potential investor.
Especially after a major breach, hardening security will be instrumental in gaining back the customer’s confidence. If you have further inquiries, please reach out and let us know how we can help. At NextGen Healthcare, we are committed to delivering better healthcare outcomes for all.
RBC Capital’s Sean Dodge was one of the pundits raising his price target; he lifted it to $23.95 per share, matching the buyout price. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. LLC is acting as financial advisor to NextGen Healthcare, and Latham & Watkins LLP is acting as legal advisor. Upon completion of the transaction, NextGen Healthcare’s common stock will no longer be listed on any public stock exchange. Style is an investment factor that has a meaningful impact on investment risk and returns.
Morningstar‘s Stock Analysis NXGN
And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. NXGN’s beta can be found in Trading Information at the top of this page. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Our Quantitative Research team models direct competitors or comparable companies
from a bottom-up perspective to find companies describing their business in a
View analysts price targets for NXGN or view top-rated stocks among Wall Street analysts. Thoma Bravo offers solutions in medication management, cardiovascular imaging, healthcare analytics, and identity and access authentication, among others. Does Thoma Bravo plan to consolidate market power with this acquisition, or will it operate the acquired company as an independent entity? Meanwhile, several changed their recommendation on the shares to neutral, as the healthcare company’s current share price isn’t likely to move much. Among these modifiers were Cantor Fitzgerald’s Sarah James and Guggenheim’s Jack Wallace, both of whom shifted their assessments down from the equivalent of buy to neutral. NextGen Healthcare (NXGN -0.09%) will soon cease to exist as a publicly traded stock, and the market said farewell by bidding up its price.
7 Wall Street research analysts have issued twelve-month price targets for NextGen Healthcare’s shares. Their NXGN share price forecasts range from $17.00 to $25.00. On average, they predict the company’s share price to reach $22.41 in the next twelve months. This suggests that the stock has a possible downside of 5.0%.
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel.
7 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for NextGen Healthcare in the last year. There are currently 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” NXGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NXGN, but not buy additional shares or sell existing shares. NextGen Healthcare, Inc., a cloud-based healthcare technology solution provider, announced that it has entered into a definitive agreement to be acquired by private equity firm Thoma Bravo.
How has NXGN performed historically compared to the market?
This site is protected by reCAPTCHA and the Google
Terms of Service apply. The next few months will be interesting as multiple law firms are investigating whether NextGen board members violated their fiduciary responsibilities in this transaction. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns. Eric Volkman has no position in any of the stocks mentioned.
- The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018.
- There are currently 6 hold ratings and 1 buy rating for the stock.
- One share of NXGN stock can currently be purchased for approximately $23.60.
- Even though the market finished the month strong, these stocks dropped.
- Among these modifiers were Cantor Fitzgerald’s Sarah James and Guggenheim’s Jack Wallace, both of whom shifted their assessments down from the equivalent of buy to neutral.
After all, PE firms are looking to generate a positive return on their investments. NextGen Healthcare supports rigorous industry and regulatory standards so that our clients can successfully participate in various quality reporting and incentive programs. The acquisition is expected to enhance shareholder value and maximize NextGen Healthcare for future growth and success. The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 24th 2023. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements.
They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends. NextGen Healthcare Inc is a United States-based company that provides healthcare solutions.